Therapeutic evaluation and prognostic value of interim hybrid PET/CT with ¹⁸F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma

By Zhao Jinhua   Qiao Wenli   Wang Chun   Wang Taisong   Xing Yan  

Hematology, Vol. 12, Iss. 5, 2007-10 ,pp. : 423-430

Maney Publishing

Access to resources Recommend Favorite

FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease

By Querellou Solène   Valette Frédéric   Bodet-Milin Caroline   Oudoux Aurore   Carlier Thomas   Harousseau Jean-Luc   Chatal Jean-François   Couturier Olivier  

Annals of Hematology, Vol. 85, Iss. 11, 2006-11 ,pp. : 759-767

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

By Sieniawski Michal   Staak Oliver   Glossmann Jan-Peter   Reineke Thorsten   Scheuß Helena   Diehl Volker   Engert Andreas   Josting Andreas  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 107-115

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey

By Sucak Gülsan Türköz   Çakar Merih Kızıl   Suyanı Elif   Akı Zeynep   Altındal Şermin   Acar Kadir  

Hematology, Vol. 18, Iss. 5, 2013-09 ,pp. : 269-276

Maney Publishing

Access to resources Recommend Favorite

The Use of Positron Emission Tomography with [₁₈F] 2-Fluoro-_d-2-Deoxyglucose (FDG-PET) in Hodgkin and Non-Hodgkin's Lymphoma

By Chiusolo Patrizia   Sica Simona   Leone Giuseppe  

Hematology, Vol. 8, Iss. 6, 2003-12 ,pp. : 403-408

Maney Publishing

Access to resources Recommend Favorite